

A provider's guide to helping patients find Divigel in stock in 2026. Includes 5 actionable steps, alternatives, and workflow tips for your practice.
You've prescribed Divigel (Estradiol gel 0.1%) because it's the right fit for your patient — flexible dosing, transdermal delivery, and well-tolerated. But then the call comes: "My pharmacy doesn't have it." Or worse, the patient simply doesn't fill the prescription and misses weeks of therapy.
This scenario has become increasingly common as the hormone replacement therapy (HRT) market faces sustained demand pressure. While Divigel is not formally in shortage, pharmacy-level availability remains inconsistent. As a prescriber, there are concrete steps you can take to close this gap and keep your patients on track.
As of 2026, Divigel's manufacturer, Vertical Pharmaceuticals, reports that supply remains adequate at the distribution level. The disconnect between supply and patient access typically occurs at the pharmacy level:
For a full supply timeline, see our provider shortage briefing.
Understanding the patient experience helps frame the problem. Common reasons patients report difficulty:
Writing for "Estradiol gel 0.1%" rather than "Divigel" gives pharmacies more flexibility to dispense what they have in stock. Generic Estradiol gel is bioequivalent and available from multiple manufacturers. The cost difference is significant:
Unless there's a specific clinical reason to require the brand, generic prescribing improves both access and affordability.
Medfinder allows patients (and your staff) to check real-time pharmacy availability for Divigel and generic Estradiol gel. Integrating a quick Medfinder recommendation into your prescribing workflow can prevent the "I couldn't find it" callback.
Consider adding a note to your after-visit summary: "If your pharmacy doesn't have this medication in stock, visit Medfinder.com to find a nearby pharmacy that does."
If your area has independent pharmacies, recommend them as a first option. They're often better positioned to order specialty products and may have relationships with multiple wholesalers. Compounding pharmacies can also prepare Estradiol gel formulations, though these are not FDA-approved and may not be covered by insurance.
Advise patients to start the refill process 5 to 7 days before their current supply runs out. This builds in time for the pharmacy to source the product if it's not immediately on the shelf. Most insurance plans allow refills at the 75% to 80% mark of the prescription period.
When prescribing Divigel or Estradiol gel, consider documenting an alternative therapy in case of access failure. Options include:
Approximate dose equivalencies for switching:
For a patient-facing alternatives guide to share, see: Alternatives to Divigel.
Here's a quick-reference comparison for your prescribing toolkit:
Divigel is a well-suited transdermal estradiol option for many menopausal patients, but access barriers mean prescribers need to be proactive. By prescribing generically, directing patients to Medfinder, and having backup alternatives ready, you can significantly reduce treatment interruptions.
For additional resources: Divigel Shortage: Provider Briefing | How to Help Patients Save Money on Divigel
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.